Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly Triggers Our Confirmed Buy Signal (Technical Analysis)
09:37am, Monday, 12'th Aug 2024
Eli Lilly and Company triggered a Buy signal after a price pop from the latest earnings report. Technical Buy signals, including Full Stochastic and MACD crossover, indicate upward momentum and potent
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
09:15am, Monday, 12'th Aug 2024
The recent sell-off brought biopharma stocks down by a bit. Nothing has changed about their ability to compete.
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lil
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
09:05am, Sunday, 11'th Aug 2024
A blood test that checks for an abnormal protein could detect 90% of Alzheimer's cases. Eli Lilly recently obtained approval for an early Alzheimer's treatment, Kisunla.
3 Stocks to Load-Up On Before Autumn Arrives
06:32am, Saturday, 10'th Aug 2024
Despite the volatility seen this summer, certain stocks are managing to outperform the broader market. Strong second-quarter financial results and positive forward guidance have propelled some stocks
Stock Market This Week: LLY Rallies on Drug Revenue, SMCI Plunges Despite Growth, DIS Ups & Downs
05:04pm, Friday, 09'th Aug 2024
A volatile week in the stock market ends with the Nasdaq-100 snapping its weekly losing streak, but all other indices closed down in the red. Eli Lilly (LLY) rallied, SuperMicro (SMCI) plummeted, and
Eli Lilly And Co LLY reported on Thursday second-quarter revenue of $11.3 billion, up 36% year-over-year, easily surpassing the consensus of $9.95 billion.
Eli Lilly Stock Keeps Climbing After Drugmaker's Strong Earnings Report
02:50pm, Friday, 09'th Aug 2024
Investors of Eli Lilly (LLY) continued to ride the wave created by the pharmaceutical firm's powerhouse second-quarter earnings report.
What Eli Lilly, Novo Nordisk earnings show about GLP-1 sales
01:07pm, Friday, 09'th Aug 2024
Recent earnings from Eli Lilly and Company (LLY) and Novo Nordisk (NVO) highlight the demand for GLP-1 drugs and why not all GLP-1 providers may be created equal. Yahoo Finance senior healthcare repor
3 Dynamite Stocks to Load Up On For the Next Major Bull Market Rally
12:16pm, Friday, 09'th Aug 2024
Long-term stocks, or those that are meant to be held for over a year, let investors ignore daily market fluctuations.
3 Healthcare Stocks to Sell in August Before They Crash & Burn
12:02pm, Friday, 09'th Aug 2024
The stock market is currently in a rotation. Traders are moving capital from aggressive growth and technology names to find safety in other sectors of the market.
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lill
These stocks join Meta and Eli Lilly as the biggest winners this earnings season
08:14am, Friday, 09'th Aug 2024
We're nearing the end of second-quarter earnings season, so this is a good moment to screen the S&P 500 and show which companies increased revenue the most while also improving their profit margins.
It's Too Soon to Buy the Dip in Weight Loss Drugmakers
07:00am, Friday, 09'th Aug 2024
Obesity drugmakers like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO were not immune to the broad market sell-off sparked by the June CPI report, but investors looking to get into these names should
2 Healthcare Stocks to Buy Hand Over Fist in August
06:02am, Friday, 09'th Aug 2024
Eli Lilly is a leader in diabetes and obesity care, but it's also making progress elsewhere. Johnson & Johnson has a robust underlying business, and a rare and ongoing dividend streak.
